USA - NASDAQ:BKYI - US09060C5076 - Common Stock
The current stock price of BKYI is 0.7606 USD. In the past month the price decreased by -1.04%. In the past year, price decreased by -28.3%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MSFT | MICROSOFT CORP | 37.39 | 3791.07B | ||
ORCL | ORACLE CORP | 49.33 | 856.52B | ||
NOW | SERVICENOW INC | 61.24 | 197.68B | ||
PANW | PALO ALTO NETWORKS INC | 60.81 | 135.87B | ||
CRWD | CROWDSTRIKE HOLDINGS INC - A | 123.07 | 111.80B | ||
FTNT | FORTINET INC | 31 | 61.52B | ||
ZS | ZSCALER INC | 85.2 | 43.51B | ||
CYBR | CYBERARK SOFTWARE LTD/ISRAEL | 133.38 | 24.20B | ||
NBIS | NEBIUS GROUP NV | 75.87 | 22.46B | ||
CHKP | CHECK POINT SOFTWARE TECH | 20.62 | 21.30B | ||
GEN | GEN DIGITAL INC | 12.3 | 17.65B | ||
RBRK | RUBRIK INC-A | N/A | 14.59B |
BIO-key International, Inc. engages in the provision of an identity and access management platform. The company is headquartered in Holmdel, New Jersey and currently employs 41 full-time employees. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
BIO-KEY INTERNATIONAL INC
101 Crawfords Corner Rd, Suite 4116
Holmdel NEW JERSEY 07719 US
CEO: Michael W. DePasquale
Employees: 42
Phone: 17323591100
The current stock price of BKYI is 0.7606 USD. The price decreased by -9.03% in the last trading session.
The exchange symbol of BIO-KEY INTERNATIONAL INC is BKYI and it is listed on the Nasdaq exchange.
BKYI stock is listed on the Nasdaq exchange.
7 analysts have analysed BKYI and the average price target is 2.04 USD. This implies a price increase of 168.21% is expected in the next year compared to the current price of 0.7606. Check the BIO-KEY INTERNATIONAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BIO-KEY INTERNATIONAL INC (BKYI) has a market capitalization of 5.22M USD. This makes BKYI a Nano Cap stock.
BIO-KEY INTERNATIONAL INC (BKYI) currently has 42 employees.
BIO-KEY INTERNATIONAL INC (BKYI) has a support level at 0.74 and a resistance level at 0.77. Check the full technical report for a detailed analysis of BKYI support and resistance levels.
The Revenue of BIO-KEY INTERNATIONAL INC (BKYI) is expected to decline by -5.83% in the next year. Check the estimates tab for more information on the BKYI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BKYI does not pay a dividend.
BIO-KEY INTERNATIONAL INC (BKYI) will report earnings on 2025-11-12.
BIO-KEY INTERNATIONAL INC (BKYI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.2).
The outstanding short interest for BIO-KEY INTERNATIONAL INC (BKYI) is 0.78% of its float. Check the ownership tab for more information on the BKYI short interest.
ChartMill assigns a fundamental rating of 2 / 10 to BKYI. BKYI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months BKYI reported a non-GAAP Earnings per Share(EPS) of -1.2. The EPS increased by 89.08% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -38.3% | ||
ROE | -58.78% | ||
Debt/Equity | 0.07 |
7 analysts have analysed BKYI and the average price target is 2.04 USD. This implies a price increase of 168.21% is expected in the next year compared to the current price of 0.7606.
For the next year, analysts expect an EPS growth of 70.43% and a revenue growth -5.83% for BKYI